CAMBRIDGE, Mass., June 24, 2021 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ: NTLA), a leading genome editing company focused on...
TORONTO, June 24, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce the...
DENVER, June 24, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’),...
Phase 2 trial expected to begin in the first quarter of 2022BASEL, Switzerland, June 24, 2021 (GLOBE NEWSWIRE) -- VectivBio...
Completed an initial public offering with net proceeds, including the exercise of the underwriters’ option in full, of approximately $48.4...
4D-110: Initial clinical safety data at both of the two dose levels in the Phase 1 clinical trial indicate that...
EDEN PRAIRIE, Minn., June 24, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (Nasdaq: MIRO) ("Miromatrix"), a life sciences company pioneering...
Primary endpoint, change in DUX4-driven gene expression which was included as an experimental biomarker, was not metLosmapimod showed statistically significant*...
BOSTON, June 24, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience...
CAMBRIDGE, Mass., June 24, 2021 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc., an innovative biopharmaceutical company pioneering the development of conditionally...
MONTEGO BAY, Jamaica, June 24, 2021 (GLOBE NEWSWIRE) -- Silo Wellness Inc. (“Silo Wellness” or the “Company”) (CSE: SILO) (OTC:...
Allergy Therapeutics plc (“Allergy Therapeutics”, “ATL” or the “Group”) Trading update Operating profit strong and expected to be well ahead...
Company announcement – No. 41/ 2021 Zealand Pharma Announces U.S. Commercial Availability of ZEGALOGUE® (dasiglucagon) injection ZEGALOGUE now available in...
- Activities to support the next stage of clinical development of ACHM B3 candidate are ongoing- - Dosing of pediatric...
Encouraging Pharmacokinetics, Pharmacodynamics and Safety Profile at 15mg/kg of AVB-500HOUSTON, June 24, 2021 (GLOBE NEWSWIRE) -- Aravive Inc. (Nasdaq: ARAV),...
●Acquisition Strengthens USAQ Business Model and Strategic Position●Purchase includes AllergiEnd® Method Patent, Trademark and Website●AllergiEnd®’s Product Portfolio Favorably Aligned with...
RESEARCH TRIANGLE PARK, N.C., June 24, 2021 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company...
Prof. Nutt Will Drive Progression of a Pipeline of New Psychedelic Medicines, Helping to Define a Clear Development Pathway to...
Toronto, Ontario--(Newsfile Corp. - June 24, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its...